← Eichor
Condition: Malignant Respiratory Tract Neoplasm Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Malignant Respiratory Tract Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoi
NA · 1 location(s) · M.D. Anderson Cancer Center · NCT03422302The IMmunotherapy Pleural 5-ALA PDT
Phase 2 · 1 location(s) · University Hospital, Lille · NCT04400539Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease
Phase 1 · 1 location(s) · David Bartlett, MD · NCT07192900The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082Impact of Patient Position on Chemical Pleurodesis by Chest Ultrasound
NA · 1 location(s) · Ain Shams University · NCT07147270ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG
NA · 1 location(s) · Cambridge University Hospitals NHS Foundation Trust · NCT06959719A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Phase 1 · 3 location(s) · RasCal Therapeutics, Inc. · NCT04678648A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Phase 1/Phase 2 · 25 location(s) · Merck Sharp & Dohme LLC · NCT07286149The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Phase N/A · 1 location(s) · VastBiome · NCT05037825Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815New Method to Differentiate Benign and Malignant Pulmonary Nodules.
Phase N/A · 1 location(s) · China-Japan Friendship Hospital · NCT06056999UNC Pleural Fluid Registry
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05620329A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC
Phase 2 · 1 location(s) · Sichuan University · NCT06769295Safety and Efficacy of NK510 to Treat NSCLC
EARLY_Phase 1 · 1 location(s) · Base Therapeutics (Shanghai) Co., Ltd. · NCT06097962A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors
Phase 1 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07250386First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
Phase 2 · 2 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT05188859A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Phase 1/Phase 2 · 4 location(s) · OncoResponse, Inc. · NCT06090266Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer
Phase 2 · 26 location(s) · Teligene US · NCT05168566MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer
Phase N/A · 2 location(s) · European Institute of Oncology · NCT05974475Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
Phase N/A · 1 location(s) · Baohui Han · NCT07399210Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-
Phase 2 · 1 location(s) · City of Hope Medical Center · NCT05830058dENdritic Cell Therapy Combined With SURgEry in Mesothelioma
Phase 1 · 1 location(s) · Erasmus Medical Center · NCT05304208A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · 37 location(s) · Aurigene Discovery Technologies Limited · NCT05865002CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Phase 1 · 63 location(s) · BeOne Medicines · NCT06120283Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884Enhanced COPD Management in Suspected Lung Cancer Patients
NA · 1 location(s) · Ditte Krag-Hansen · NCT07543601Histiocytic Disorder Follow-up Study
Phase N/A · 1 location(s) · University of Alabama at Birmingham · NCT05915208Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid
Phase 1 · 1 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06126406FL-261 Imaging for Cancer Diagnosis and Staging
Phase N/A · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07510321
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.